Evidence map›Paper›PMID 41799791›Full record

ReviewActa biochimica Polonica2026

Structural potential of the 5' noncoding regions of the mRNAs encoding p53 isoforms.

Mariola Dutkiewicz, Paulina Zydowicz-Machtel

Abstract readReview
In one paragraph

Review in Acta biochimica Polonica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mariola DutkiewiczInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.
Paulina Zydowicz-MachtelInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Famous for its nickname "guardian of the genome," the p53 protein acts, among other things, as a transcription factor in the form of a tetramer, which may consist of different types of p53 isoforms. They differ in length and content of specific domains that are responsible for their functions. The way this factor acts, sometimes opposite to what we would expect from the main protein isoform, depends on which isoforms form the tetramer. There are over a dozen isoforms of the human p53 protein encoded by a single gene, thanks to the use of different transcriptional promoters (DNA level), alternative splicing (pre-mRNA level), and different translation initiation sites (mRNA level).

Indexed as

5' Untranslated RegionsRNA, MessengerTumor Suppressor Protein p53Alternative SplicingAnimalsHumansNucleic Acid ConformationProtein Isoforms5' Untranslated RegionsProtein IsoformsRNA, MessengerTP53 protein, humanTumor Suppressor Protein p53mRNA structurep53 isoformsRNA interactionsRNA structuretranslation regulation

Identifiers

PMID41799791
PMCPMC12960278

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.